States fight bonus pay for CEO of OxyContin maker Purdue
Share:
(Reuters) - The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday.The attorneys general of 24 states said Craig Landau should not collect a bonus that would lift his pay to $3.9 million because of his alleged role in downplaying the risks of Purdue's drugs.The filing also said Purdue increased Landau's..